logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • GE Healthcare Inc. drugs

    FiltersReset Filters
    6 results

    • cerianna

      (FLUOROESTRADIOL F 18)
      GE Healthcare Inc.
      Usage: CERIANNA is indicated for use with PET imaging to detect estrogen receptor-positive lesions in patients with recurrent or metastatic breast cancer. It serves as an adjunct to biopsy, but its efficacy does not extend to other receptors like HER2 or progesterone receptor. Tissue biopsy is necessary for confirmation.

    • omnipaque - iohexol injection, solution

      (Iohexol)
      Ge Healthcare Inc.

    • omniscan

      (gadodiamide)
      GE Healthcare Inc.
      Usage: OMNISCAN is a gadolinium-based contrast agent for intravenous use in MRI, indicated for visualizing lesions with abnormal vascularity in the brain, spine, and associated tissues, as well as in the thoracic (noncardiac), abdominal, pelvic, and retroperitoneal regions.

    • optison

      (Human Albumin Microspheres and Perflutren)
      GE Healthcare Inc.
      Usage: OPTISON is indicated for patients with suboptimal echocardiograms to enhance left ventricle opacification and improve the visualization of left ventricular endocardial borders.

    • visipaque

      (Iodixanol)
      GE Healthcare Inc.
      Usage: VISIPAQUE is indicated for intra-arterial and intravenous procedures in adults and pediatric patients aged 12 and older. Uses include digital subtraction angiography, various types of arteriography, CT imaging, excretory urography, and coronary computed tomography angiography to assist in diagnosing conditions like coronary artery disease.

    • visipaque

      (Iodixanol)
      GE Healthcare Inc.
      Usage: VISIPAQUE is indicated for intra-arterial procedures (e.g., digital subtraction angiography, angiocardiography) in patients 12 years and older, and for intravenous procedures (e.g., CT imaging, excretory urography) in patients of all ages. It is also used for select pediatric imaging studies.